ASMI pleased Trans-Tasman regulatory harmonisation activities will continue despite shelving of ANZTPA proposal
20 November 2014 - The Australian Self
Medication Industry (ASMI) today said it is pleased the Federal
Government is committed to continuing its co-operation with New
Zealand's Medicines and Medical Devices Safety Authority (Medsafe)
despite its decision to cease efforts to establish a joint
therapeutic products regulator, the Australia New Zealand
Therapeutic Products Agency (ANZTPA).
In responding to the Government's announcement, ASMI Executive Director Dr Deon Schoombie, said: "We have mixed feelings about the Federal Government's decision. While on the one hand we have been a supporter of the ANZTPA proposal for its potential to pave the way for a single market, we have been playing a 'waiting game' for a long time and this has created uncertainty and delays in progressing individual harmonisation initiatives.
"It's reassuring the Therapeutic Goods Administration (TGA) and Medsafe will continue to explore Trans-Tasman regulatory harmonisation activities of benefit to both countries and build on earlier projects such as over-the-counter medicines (OTC) business process reform, which is a great example of collaboration and aligning of business processes.
"ASMI believes that areas of priority for regulatory
harmonisation between Australia and New Zealand are the advertising
of OTC medicines and scheduling," Dr Schoombie added.
About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines (CM). ASMI members make up 85 per cent of the $4bn Non-Prescription Medicines market. Membership totals 50 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to advance consumer health through responsible self-care. This means driving a viable and responsible industry and empowering the consumer with evidence-based products and information with the aim of improving health and wellbeing. To find out more about ASMI or how to become an ASMI member, please visit (www.asmi.com.au).
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: email@example.com